|
1
|
Stewart BW and Wild CP: World cancer
report 2014. Lyon, France: Int Agency Res Cancer; 2014
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valmasoni M, Pierobon ES, Ruol A, De
Pasqual CA, Zanchettin G, Moletta L, Salvador R, Costantini M and
Merigliano S: Endoscopic tumor length should be reincluded in the
esophageal cancer staging system: Analyses of 662 consecutive
patients. PLoS One. 11:e01530682016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghidini M, Petrelli F, Hahne JC, De Giorgi
A, Toppo L, Pizzo C, Ratti M, Barni S, Passalacqua R and Tomasello
G: Clinical outcome and molecular characterization of brain
metastases from esophageal and gastric cancer: A systematic review.
Med Oncol. 34:622017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barroso-Deljesus A, Lucena-Aguilar G,
Sanchez L, Ligero G, Gutierrez-Aranda I and Menendez P: The Nodal
inhibitor Lefty is negatively modulated by the microRNA miR-302 in
human embryonic stem cells. FASEB J. 25:1497–1508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo T, Wei Y, Lv S, Zhang C and Tian Y:
MiR-302a inhibits the tumorigenicity of ovarian cancer cells by
suppression of SDC1. Int J Clin Exp Pathol. 8:4869–4880.
2015.PubMed/NCBI
|
|
10
|
Zhang GM, Bao CY, Wan FN, Cao DL, Qin XJ,
Zhang HL, Zhu Y, Dai B, Shi GH and Ye DW: MicroRNA-302a suppresses
tumor cell proliferation by inhibiting Akt in prostate cancer. PLoS
One. 10:e01244102015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maadi H, Moshtaghian A, Taha MF, Mowla SJ,
Kazeroonian A, Haass NK and Javeri A: Multimodal tumor suppression
by miR-302 cluster in melanoma and colon cancer. Int J Biochem Cell
Biol. 81:1212016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu N, Li J, Zhao Z, Han J, Jiang T, Chen
Y, Hou N and Huang C: MicroRNA-302a enhances 5-fluorouracil-induced
cell death in human colon cancer cells. Oncol Rep. 37:631–639.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turjanski AG, Vaqué JP and Gutkind JS: MAP
kinases and the control of nuclear events. Oncogene. 26:3240–3253.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schubbert S, Shannon K and Bollag G:
Hyperactive Ras in developmental disorders and cancer. Nat Rev
Cancer. 7:295–308. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li P, Zhou X, Sun W, Sheng W, Tu Y, Yu Y,
Dong J, Ye B, Zheng Z and Lu M: Elemene induces apoptosis of human
gastric cancer cell line BGC-823 via extracellular signal-regulated
kinase (ERK)1/2 signaling pathway. Med Sci Monit. 23:809–817. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharmila R and Sindhu G: Evaluate the
antigenotoxicity and anticancer role of β-sitosterol by determining
oxidative DNA damage and the expression of phosphorylated
mitogen-activated protein kinases', C-fos, C-jun, and endothelial
growth factor receptor. Pharmacogn Mag. 13:95–101. 2017.PubMed/NCBI
|
|
19
|
Shaw RJ and Cantley LC: Ras, PI(3)K and
mTOR signalling controls tumour cell growth. Nature. 441:424–430.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hammerich KH, Frolov A, Li R, Ittmann M
and Ayala GE: Cellular interactions of the phosphorylated form of
AKT in prostate cancer. Hum Pathol. 63:98–109. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Shi B, Li Y and Yin F: Polydatin
inhibits cell proliferation and induces apoptosis in laryngeal
cancer and HeLa cells via suppression of the PDGF/AKT signaling
pathway. J Biochem Mol Toxicol. 31:2017. View Article : Google Scholar
|
|
22
|
Hong Y, Wen C, Du X, Hong Y, Chen W, Du X,
Ning H, Chen H, Shi R, Lin S, et al: Upregulation of
sex-determining region Y-box 9 (SOX9) promotes cell proliferation
and tumorigenicity in esophageal squamous cell carcinoma.
Oncotarget. 6:31241–31254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mundi PS, Sachdev J, McCourt C and
Kalinsky K: AKT in cancer: New molecular insights and advances in
drug development. Br J Clin Pharmacol. 82:943–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Briest F and Grabowski P:
PI3K-AKT-mTOR-signaling and beyond: The complex network in
gastroenteropancreatic neuroendocrine neoplasms. Theranostics.
4:336–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carpenter RL, Sirkisoon S, Zhu D, Rimkus
T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, et al:
Combined inhibition of AKT and HSF1 suppresses breast cancer stem
cells and tumor growth. Oncotarget. 8:73947–73963. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamilton G, Abraham AG, Morton J, Sampson
O, Pefani DE, Khoronenkova S, Grawenda A, Papaspyropoulos A,
Jamieson N, McKay C, et al: AKT regulates NPM dependent ARF
localization and p53mut stability in tumors. Oncotarget.
5:6142–6167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu N, Li J, Zhao Z, Han J, Jiang T, Chen
Y, Hou N and Huang C: MicroRNA-302a enhances 5-fluorouracil-induced
cell death in human colon cancer cells. Oncol Rep. 37:631–639.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cai N, Wang YD and Zheng PS: The
microRNA-302-367 cluster suppresses the proliferation of cervical
carcinoma cells through the novel target AKT1. RNA. 19:85–95. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun S, Zhang G, Wu Z, Shi W, Yang B and Li
Y: MicroRNA-302a functions as a putative tumor suppressor in colon
cancer by targeting Akt. PLoS One. 9:e1159802014. View Article : Google Scholar : PubMed/NCBI
|
